Earnings season presents buying opportunities for stocks that have experienced a dip in price after reporting Q1 earnings. Enterprise Products Partners offers a 7% yield and has strong fundamentals...

CVS Health Corp (NYSE:CVS) copped a downgrade from buy to neutral from UBS today after the US pharmacy chain downwardly revised its full-year profit 2024 guidance amid rising medical costs in its M...

Major U.S. equities indexes were mixed as the Federal Open Market Committee (FOMC) wrapped up its latest policy meeting, announcing it would maintain the federal funds rate at the decades-long high...

The volatile consumer healthcare sector showed up big in CVS' Q1 earnings Wednesday (May 1), with solid revenue from its store operations but a warning about revenue projections due to its foray in...

CVS Health Corp (NYSE:CVS) shares tanked after the pharmacy chain downwardly revised its full-year profit 2024 guidance amid rising medical costs in its Medicare insurance business.   The company i...

CVS faced higher-than-expected costs in its insurance business. Lower Medicare Advantage reimbursement rates are expected to weigh on its performance.

CVS Health's (CVS) Q1 performance is impacted by a decline in the Health Services segment due to continued pharmacy client price improvements.

CVS Health came up short of Q1 earnings estimates and slashed its full-year outlook as medical costs surged. Here's what you need to know.

CVS Health Corporation (NYSE:CVS ) Q1 2024 Earnings Conference Call May 1, 2024 8:00 AM ET Company Participants Karen Lynch - President, Chief Executive Officer Tom Cowhey - Chief Financial Officer...

The shares of CVS Health Corp (NYSE:CVS) are plummeting today, down 18% at $55.55 at last glance and earlier as low as $54.04.

The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street est...

Shares of CVS Health Corporation are taking a beating in premarket trading this morning. As of the time of this writing, CVS stock is down over 12% to $59.49 per share.

CVS Health (CVS) came out with quarterly earnings of $1.31 per share, missing the Zacks Consensus Estimate of $1.69 per share. This compares to earnings of $2.20 per share a year ago.

CVS Health (CVS) shares tumbled close to 12% in pre-market trading Wednesday after the retail pharmacy giant posted first-quarter results that missed analysts' estimates and lowered its guidance fo...

CVS and other insurers have seen medical costs spike as many Medicare Advantage patients return to hospitals to undergo procedures they delayed during Covid.